These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15905598)

  • 21. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
    Jung R; MacLaren R
    Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
    Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
    Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials.
    Wang CH; Ma MH; Chou HC; Yen ZS; Yang CW; Fang CC; Chen SC
    Arch Intern Med; 2010 May; 170(9):751-8. PubMed ID: 20458081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of Oral Proton Pump Inhibitors in Acute, Nonvariceal Upper Gastrointestinal Bleeding: A Network Meta-Analysis.
    Rodriguez EA; Donath E; Waljee AK; Sussman DA
    J Clin Gastroenterol; 2017 Sep; 51(8):707-719. PubMed ID: 27505402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress-induced ulcer bleeding in critically ill patients.
    Ali T; Harty RF
    Gastroenterol Clin North Am; 2009 Jun; 38(2):245-65. PubMed ID: 19446257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

  • 37. Esomeprazole for the treatment of peptic ulcer bleeding.
    den Hoed CM; Kuipers EJ
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates and economic outcomes of proton pump inhibitor use by routes in intensive care unit patients.
    Sankaranarayanan J; Reardon T; Olsen KM
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):741-9. PubMed ID: 25059290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.